Healixa Inc.
OTC:EMOR
0.27 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.128 | 0.208 | 0.181 | 0.177 | 0.033 | 0.009 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.087 |
| Cost of Revenue
| 0.119 | 0.093 | 0.098 | 0.073 | 0.132 | 0.009 | 0.008 | 0 | 0 | 0.023 | 0 | 0 | 0 | 0.022 |
| Gross Profit
| 0.009 | 0.115 | 0.083 | 0.104 | -0.098 | -0 | -0.008 | 0 | 0 | -0.023 | 0 | 0 | 0 | 0.065 |
| Gross Profit Ratio
| 0.068 | 0.552 | 0.456 | 0.586 | -2.959 | -0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.745 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0.187 | 2.467 | 0.247 | 0.424 | 3.418 | 0 | 1.743 | 2.071 | 0.736 | 4.408 | 1.663 | 1.665 | 0.5 | 0.696 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0.009 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 0.187 | 2.467 | 0.247 | 0.424 | 3.418 | 0.009 | 1.743 | 2.071 | 0.736 | 4.408 | 1.663 | 1.665 | 0.5 | 0.696 |
| Operating Income
| -0.178 | -2.352 | -0.164 | -0.321 | -3.517 | 0.009 | -1.751 | -2.071 | -0.736 | -4.431 | -1.663 | -1.665 | -0.5 | -0.631 |
| Operating Income Ratio
| -1.395 | -11.328 | -0.907 | -1.811 | -105.68 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.257 |
| Total Other Income Expenses Net
| -0.033 | -0.083 | -0.098 | -0.102 | -0.093 | 4.117 | -0.071 | -0.142 | -0.001 | -0.508 | -0.234 | 0 | -0.125 | -0.005 |
| Income Before Tax
| -0.212 | -2.435 | -0.262 | -0.423 | -3.61 | 4.126 | -1.823 | -2.213 | -0.736 | -4.938 | -1.897 | -1.665 | -0.625 | -0.636 |
| Income Before Tax Ratio
| -1.655 | -11.729 | -1.45 | -2.388 | -108.474 | 467.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.311 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | -0 | -0 | 0 | -0.086 | 0 | -0 | -0.054 | -0.056 | -0.055 | 0 |
| Net Income
| -0.212 | -2.435 | -0.263 | -0.423 | -3.61 | 4.126 | -1.823 | -2.213 | -0.736 | -4.938 | -1.897 | -1.665 | -0.625 | -0.636 |
| Net Income Ratio
| -1.655 | -11.729 | -1.451 | -2.388 | -108.474 | 467.71 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.311 |
| EPS
| -0 | -0.003 | -0 | -0.001 | -0.005 | 0.005 | -0.002 | -0.003 | -0.001 | -0.006 | -0.002 | -0.002 | -0.001 | -0.001 |
| EPS Diluted
| -0 | -0.003 | -0 | -0.001 | -0.005 | 0.005 | -0.002 | -0.003 | -0.001 | -0.006 | -0.002 | -0.002 | -0.001 | -0.001 |
| EBITDA
| -0.17 | -2.344 | -0.156 | -0.312 | -3.509 | 0.018 | -1.743 | -2.071 | -0.736 | -4.408 | -1.663 | -1.665 | -0.5 | -0.615 |
| EBITDA Ratio
| -1.33 | -11.289 | -0.861 | -1.764 | -105.431 | 2.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.073 |